Relationship between three palliative care outcome scales
© Higginson and Donaldson; licensee BioMed Central Ltd. 2004
Received: 06 October 2004
Accepted: 29 November 2004
Published: 29 November 2004
Various scales have been used to assess palliative outcomes. But measurement can still be problematic and core components of measures have not been identified. This study aimed to determine the relationships between, and factorial structure of, three widely used scales among advanced cancer patients.
Patients were recruited who received home or hospital palliative care services in the south of England. Hope, quality of life and palliative outcomes were assessed by patients in face to face interviews, using three previously established scales – a generic measure (EQoL), a palliative care specific measure (POS) and a measure of hope (Herth Hope Index). Analysis comprised: exploratory factor analysis of each individual scale, and all scales combined, and confirmatory factor analysis for model building and validation.
Of 171 patients identified, 140 (81%) consented and completed first interviews; mean age was 71 years, 54% were women, 132 had cancer. In exploratory analysis of individual means, three out of the five factors in the EQoL explained 75% of its variability, four out of the 10 factors in POS explained 63% of its variability, and in the Hope Index, nine out of the 12 items explained 69% of its variability. When exploring the relative factorial structure of all three scales, five factors explained 56% of total combined variability. Confirmatory analysis reduced this to a model with four factors – self-sufficiency, positivity, symptoms and spiritual. Removal of the spiritual factor left a model with an improved goodness of fit and a measure with 11 items.
We identified three factors which are important outcomes and would be simple to measure in clinical practice and research.
Keywordspalliative care quality of life assessment hope symptoms hospice day care
Measurement of the effect of illness and its treatment on patients is now an accepted part of clinical trial design . Such measurement is also proposed as an aid to improve clinical practice and decision making [2, 3]. However, as the illness becomes more advanced the value of many well validated quality of life instruments has been challenged [4–9]. There are three main difficulties. First, many quality of life scales focus on the assessment of physical functioning, which deteriorates as illness progresses [4, 8]. This can render the measure insensitive to, or mask, other changes. Second, most quality of life scales have been validated among patients in early stage illness, such as cancer or whilst undergoing chemotherapy or curative treatment [8, 9]. Sometimes their validation was founded on an assumption that patients in terminal disease had a poorer quality of life than those at diagnosis . This assumption has been consistently challenged . Concerns among patients with more advanced illness are often different to earlier stages, as patients reframe their priorities in the face of impending death . Existential, relationships, information, the provision of care, and use of remaining time become more important . Third, collecting information from patients at late stages of disease is practically difficult; questionnaires need to be kept short, be easy to use, and be few in number. Even then there are often difficulties of missing data and loss to follow-up [8, 9].
In response to these difficulties, different measures have been developed and tested among patients receiving palliative and hospice care in different countries and contexts [8, 11]. These include scales that assess, to different degrees, symptoms, existential aspects or spirituality, the impact of therapy, hope, information, social and family concerns [8, 9, 12]. Some are completed directly by patients, some by family members or other proxies, and some by a combination of these. However, there is little information on how different measures compare, particularly in relation to more traditional measures. Clinicians and researchers need such information to determine which core factors should be measured, especially when it is not possible to collect a battery of measures. This study therefore sought to determine the relationships between three such scales and their factorial structures to recommend short, self-contained scales for future use among people with advanced cancer.
Secondary analysis of a prospective observational study.
Patients and setting
Patients living in Chichester in the South of England receiving home or hospital palliative care support, from community, hospice or hospital palliative care team staff, were approached to take part in the study. Local research ethics committee approval was obtained. The local hospice was planning to develop a day care unit and patients were recruited during this period. A historical group was recruited before the day care unit was established. Consecutive consenting patients were recruited for both series. Patients were eligible if they were in the care of the hospice home care team, or neighbouring home care teams, that had access to the day care unit. Patients were excluded if they were judged by staff to be too ill for interview, if staff felt it would distress them, or they lived outside the catchment area of the hospice day unit. Two concurrent groups were recruited after day care was established – patients who did (Group AD) and did not (Group AN) choose to receive day care.
EQoL EQ-5D. This generic questionnaire defines health in five dimensions: mobility, self-care, usual activities, pain or discomfort, and anxiety or depression. Each dimension is divided into three categories – whether the respondent has no problem, a moderate problem, or an extreme problem. A sixth item scores the person's overall health on a visual analogue (0 – 100) scale. The questionnaire has been validated and applied in a wide range of patient groups [13–16].
Palliative care Outcome Scale (POS). This 10 item scale (plus an open question) was specifically developed and validated for palliative care and covers physical symptoms, patient and family or caregiver anxiety/fears and well being. The effect of the items on the daily life of the patient over the past three days is scored on a five-point Likert scale ranging from 'none' (0) to 'overwhelmingly' (4). For example: "over the past 3 days, have you been feeling anxious or worried about your illness or treatment? (0) not at all – (4) overwhelmingly" [17, 18]. In the POS the term 'family' describes the caregiver or significant other, such as a partner, spouse or other closest individual.
Herth Hope Index (Hope). This 12 item instrument assesses hope in adults in clinical settings, and is designed to assess change. For example: "I have a positive outlook toward life? strongly disagree (1) to strongly agree (4) -". Patients are asked how much they agree with the statement right now .
Full details of the scales are shown in the Appendix 1 (see additional file 1). Patients were interviewed immediately after referral to the study. Follow-up interviews occurred but these data are not considered here.
Data were analysed separately for the historical and concurrent (post day care) groups. The relative factorial structure of the three scales was explored in two steps. First, we performed a preliminary exploratory factor analysis (EFA) on each individual scale and on all the items of the three scales combined, using Principal Component Analysis on the historical sample. Second, we performed further exploration and final validation using confirmatory factor analysis (CFA) on the combined historical and concurrent samples. The EQS software  was used to compare several models to the covariance matrix of the 28 variables. Although this was an observational follow-up study, for the purpose of this paper we always used the baseline measures, when complete data for all patients was available.
patients were identified and asked to take part in the study, 82 in the historical group, and 89 in the concurrent group (40 were AD). Of these, 140 (81%) were successfully approached, agreed to take part in the study, and completed the first interview. As shown in Table 1, 66 were from the historical group and 74 were from the concurrent group (of whom 28 were AD). Failure to interview was due to: refused 12, felt too unwell 11, died 8. Complete data in all three scales were obtained in 137 patients. As Table 1 shows the AD and AN were similar, and so were subsequently merged to form the concurrent group. The concurrent and historical samples were very similar in terms of characteristics like age, ethnicity, willingness to take part in the study, diagnosis, as well as their relationship to the carer and whether they resided with family, spouse or alone and housing. In spite of the age similarity the proportion of retired people was slightly larger in the concurrent sample. Differences between the two samples were only observed for place of death and for gender. Although not statistically significant, the concurrent sample tended to have more patients dying at home while the historical sample tended to have more patients dying in hospice. The proportion of women was larger in the historical sample (60% vs 40% P = 0.02). The distribution of cancers was similar to those in the general population.
Patient socio-demographics (completed 1st interview) for historical group and concurrent group who did (AD) and did not (AN) receive day care
Historical Group (n = 66)
Group AD (n = 28)
Group AN (n = 46)
Age in years
Working (F/T or P/T)
Not working (unable)
Lives with spouse
Lives with family
Working (F/T or P/T)
Not working (unable)
Place of death
(n = 46)
(n = 11)
(n = 22)
Summaries of the distribution of scores on the three instruments assessing hope, quality of life and palliative outcomes for the combined sample as well as results of the exploratory factor analysis, are shown in Table 4 (see additional file 2). On principal component analysis (unrotated), three factors in EQoL explained 75% of the total variability brought up by the six items in this scale. The first factor, explaining 40%, comprised general health: Health Status and the three self-sufficiency items. Anxiety-Depression defined the second factor, which explained 20% of the variability, and Pain-Discomfort formed the third factor, which explained 15% of the variability. For POS, the exploratory factor analysis grouped the 10 POS items in four factors explaining 67% of its variability. The first factor, which alone explained 27% of the variability, consisted of the two items measuring positivism (life-worthwhile and feel-good) and in addition, worry-anxiety. The second factor, which alone explained 16% of the variability, was mainly determined by information, followed by time-wasted and practical-matters. The third factor, which explained 12% of the variability, was solely determined by the item family-anxious. The fourth factor, also explaining 12% of the variability, was determined by pain and symptom-control. In the individual exploration we found that the 12 items of Hope grouped into four factors that explained approximately 69% of the variability present in the scale. The first factor was items 1, 8, 10, 11, and 12 representing positivity (39%), the second factor had items 2 and 4, measures of goals (12%), the third was items 3 and 6 (10%) and the fourth was items 7, 9 and 5 (9%). These last two factors represented a measure of support loneliness.
Three scales combined
The exploratoty factor analysis of EQoL, POS and Hope on the historical sample alone gave rather consistent results for different extraction methods. Table 4 (see additional file 2) shows the results of the unrotated principal component analysis. Five factors explained 54% of the total variability present in the three combined scales. The first principal factor, explaining 25% of the total variability of the combined scales, was determined by the three items of positivity contained in POS (share-feelings, feel-good and life worthwhile), together with all the Hope items and the anxiety items in both, POS and EQoL. The EQoL items "General Health" and items of "self-sufficiency", which constituted the most important factor of the EQoL scale, loaded together into the second factor, explaining 10% of the total variability of the combined scale. The third most important principal component, explaining 8% of the variability, comprised a general measure of patient anxiety (measured by both EQoL and POS), and family anxiety (measured by POS). The fourth principal component explained 6% of the variability and was defined by pain (measured by both EQoL and POS). The POS items "information" and "time-wasted" loaded together into the fifth factor, explaining only 6% of the total variability. In addition, the POS item "symptom control" did not load into any of these five factors and appeared to be acting independently.
One of the extractions explored was principal axis factoring with a varimax rotation. This provided a better definition of the structure, with items loading more exclusively onto one of the factors. The first factor that we had obtained with the unrotated matrix essentially separated into two. The first axis, explaining 29% of the variability, was defined by the POS item "life worthwhile" loading with those items of Hope that reflected positivity and direction: positive outlook, goals, inner strength, loving, sense of direction, days have potential and life has value. The second axis, explained 11% of the variability and contained the anxiety items of EQoL and POS, the "feel good" and "share feeling" items of POS and the items of Hope that reflected pessimism or anxiety: "alone", "scared of future" and "past memories". The third factor was the EQoL general health and self-sufficiency and explained 7% of the variability. The fourth factor was solely defined by the pain items in EQoL and POS and explained 6% of the variability. The rest of the items played only a minor role. The POS items: practical matters, information and time wasted loading in a minor factor while the POS item "family-anxious" and the Hope items "tunnel" and "faith" disappeared altogether from the rotated matrix. Therefore, the model derived from this data is one in which the following items are omitted: POS2 and POS4 from the POS scale and Hope4 Hope5 from the Hope scale, leaving the rest of the items to define four major latent factors in the following manner: Spiritual, positivity, symptoms and self-sufficiency.
Confirmatory Factor Analysis (CFA)
Goodness of fit summaries for the four models derived by Confirmatory Factor Analysis (CFA)
Average standardised residuals
Average off-diagonal st. residuals
Akaike's information criterion (AIC)
Bozodgan's version of AIC (C-AIC)
Comparative Fit Index (CFI)
Normed Fit Index (NFI)
Non-normed Fit Index (NNFI)
The factorial structure of the proposed model (MLE Estimators of regression coefficients (Standard Error)
Scared of future
Sense of direction
Life has value
In all the models presented, the matrix was positively definite, the test of independence was significant and the frequency distribution of the standardised residuals was symmetrical around 0. Models 3 and 4, not only omit the superfluous items but also separate the factors on clinical considerations. Both provide a huge improvement over the first two models. Model 3 allowed for a high correlation between the positivity and spiritual factors. More remarkably, the results show that Model 4, which disposes completely of the spiritual factor defined by the remaining Hope items, is an enormous improvement on the other models. The chi-square statistic was greatly reduced and almost reached the threshold indicating that no lack of fit was detected.
An important next step in quality of life measurement is the translation of measurement into clinical practice to improve patient care . One important barrier among patients with advanced illness is ensuring that relevant items are captured from a sufficiently small range of instruments relevant to this stage of illness. The three measures used in this study all have relevance in advanced illness. The EQoL deals with general aspects of health related quality of life, generating within the scale 243 possible health states. It has been used to provide indexed preferences for health states , and health state valuations in national and cross cultural studies . Standardised measures, such as the Medical Outcome Study (MOS) short form 12 (SF-12) map to this scale . Among our patients with advanced illness, primarily cancer, we found variability within the EQoL, although patients tended to score at the poorer end of the scale. Health status and the self-sufficiency items of mobility, self-care and usual activities explained 40% of the variation of this scale in our patient population. We included the self-sufficiency aspect in our model of summary factors, but it is debatable whether items such as mobility, self-care and usual activities are relevant outcomes in palliative care. Functional status and those items within quality of life measures that reflect functional status are highly correlated to survival , thus the scores will inevitably deteriorate towards death. However, to provide consistency with other scales used in general health care and cancer treatment, measurement may be valuable .
A factor which we entitled 'positivity' appeared to be highly important among people with advanced illness. Spirituality/positivity has also been related to communication outcomes . In the exploratory factor analysis it explained 24% of the total variability of the combined scales. Its importance was maintained in the confirmatory factor analysis. In model 3 positivity could be seen as separate from spirituality, but if a smaller model is required, spirituality can be assessed through positivity, because it is strongly correlated. Items that reflect this domain of positivity are found in a number of measures of palliative care [9, 12, 18]. However, our study is the first to quantify the extent to which this positive domain is relevant in patients with advanced illness. Our data suggests it can be measured in a variety of ways, through questions related to sharing feelings, feeling good, anxiety, as well as questions directly tapping hope.
When attempting to develop a reduced scale we identified two models, one with four factors (19 items) and another one with three factors which provided a good fit (11 items). All the Herth Hope items are excluded from the latter model, which captured self-sufficiency, symptoms and positivity. Positivity appeared very close to spirituality, as measured by the Hope index. Further work is needed to determine the relationship of these questions with specific spirituality scales [27–29].
Symptom control was absent in the structures obtained by EFA. We suspected that this was because this item was not a structured question designed for any specific symptom, but elicited in an open way what symptoms had troubled the patient. In the CFA this item loaded with the General Health status factor. Measures which specifically address symptoms are available and have been used in palliative care populations [29, 30]. Work with the POS has now developed to separate symptom modules and these are in the process of further testing and validation .
Special attention was given to the three items forming the practical factor in POS. The information item in POS (POS-5) was constant in the concurrent sample and only a few patients in the historical sample recorded non zero for this item. The time wasted item of POS was also essentially constant. It may be that the grading for these items needs to be reviewed to ensure that they give greater sensitivity to change. In our analysis this could have contributed to the poor fit shown when attempting to fit a general POS factor containing these items. It may also be because that none of the three items is an indicator of QOL; they are rather items of the provision of health care. In this study all of the patients were in receipt of a wide range of services, including specialist care teams and their practical needs were likely to have been met. Research among patients in different circumstances has shown deficiencies in these aspects of care [32, 33].
The POS item family-anxious was intriguing. It did not disrupt the validity of the model but if kept and loaded in the positivity factor, it reduced the goodness of fit. This item also showed erratic behaviour in the exploratory factor analysis. Family anxiety may be related to a large number of factors, some of which are determined by the circumstances of the patient and some of which are determined by other events. Family needs often increase as patients deteriorate and are difficult to resolve. Further work is required directly targeting the needs of families .
Our study was limited by the comparison of these scales among patients in one setting: we do not know if similar results would be found if patients were not in receipt of specialist palliative care available in the United Kingdom. However, our findings are consistent with other work assessing quality of life measurement in palliative care and in advanced cancer . Correlation between the scales may also have occurred because individuals were aware of the answers they had given for the different scales. It would be impossible to avoid this process in the completion of the questionnaires. We did not vary the order in which the questionnaires were administered. However, we believed that the questions appeared to be sufficiently different for patients not to be influenced by their prior responses. Future research should analyse this.
Our reduced model suggests that clinicians may sensibly target quality of life measurement in advanced cancer towards three main components, positivity, self-sufficiency, and symptoms. This might be achieved by the 12 items in model 4 of our factor analysis. Such a scale would be short and simple to use in both clinical practice and research, improving the measurement of outcomes in this population.
We thank the staff, patients and families at Chichester hospice, in particular Dr Brendan Amesbury, Medical Director, for their participation in this study, Danielle Goodwin and members of the Project Advisory Group for their participation in study design and data collection and Professor Brian Everitt for helpful discussions. We thank the NHS Executive, South East, for funding this project.
- Bottomley A, Efficace F, Thomas R, Vancoorden V, Ahmedzai SH: Health-related quality of life in non-small-cell lung cancer: methodologic issues in randomized controlled trials. J Clin Oncol 2003, 21: 2982–2992. 10.1200/JCO.2003.01.203PubMedView ArticleGoogle Scholar
- Levine MN, Ganz PA: Beyond the development of quality-of-life instruments: where do we go from here? J Clin Oncol 2002, 20: 2215–2216. 10.1200/JCO.20.2.405PubMedView ArticleGoogle Scholar
- Higginson IJ, Carr AJ: Measuring quality of life: Using quality of life measures in the clinical setting. BMJ 2001, 322: 1297–1300. 10.1136/bmj.322.7297.1297PubMed CentralPubMedView ArticleGoogle Scholar
- McMillan SC, Weitzner MA: Methodologic issues in collecting data from debilitated patients with cancer near the end of life. Oncol Nurs Forum 2003, 30: 123–129.PubMedView ArticleGoogle Scholar
- Rustoen T, Fossa SD, Skarstein J, Moum T: The impact of demographic and disease-specific variables on pain in cancer patients. J Pain Symptom Manage 2003, 26: 696–704. 10.1016/S0885-3924(03)00239-2PubMedView ArticleGoogle Scholar
- Hahn EA, Cella D: Health outcomes assessment in vulnerable populations: measurement challenges and recommendations. Arch Phys Med Rehabil 2003, 84: S35-S42. 10.1053/apmr.2003.50245PubMedView ArticleGoogle Scholar
- Di Maio M, Perrone F: Quality of life in elderly patients with cancer. Health and Quality of Life Outcomes 2003, 1: 44. 10.1186/1477-7525-1-44PubMed CentralPubMedView ArticleGoogle Scholar
- Hearn J, Higginson IJ: Outcome measures in palliative care for advanced cancer patients: a review. J Public Health Med 1997, 19: 193–199.PubMedView ArticleGoogle Scholar
- Cohen SR, Mount BM, Tomas JJN, Mount LF: Existential well-being is an important determinant of quality of life: Evidence from the McGill Quality of Life Questionnaire. Cancer 1996, 77: 576–586. Publisher Full Text 10.1002/(SICI)1097-0142(19960201)77:3<576::AID-CNCR22>3.0.CO;2-0PubMedView ArticleGoogle Scholar
- Spitzer WO, Dobson AL, Hall J, Chesterman E, Levi J, Shepherd R, Battista RN, Catchlove BR: Measuring the quality of life of cancer patients: a concise QL- Index for use by physicans. J Chron Dis 1980, 34: 585–597. 10.1016/0021-9681(81)90058-8View ArticleGoogle Scholar
- Kaasa S, Loge JH: Quality of life in palliative care: principles and practice. Palliat Med 2003, 17: 11–20. 10.1191/0269216303pm662raPubMedView ArticleGoogle Scholar
- Steinhauser KE, Bosworth HB, Clipp EC, McNeilly M, Christakis NA, Parker J, Tulsky JA: Initial assessment of a new instrument to measure quality of life at the end of life. Journal of Palliative Medicine 2002, 5: 829–841. 10.1089/10966210260499014PubMedView ArticleGoogle Scholar
- Brazier J, Jones N, Kind P: Testing the validity of the EuroQoL and comparing it with the SF-36 health survey questionnaire. Qual Life Res 1993, 2: 169–180. 10.1007/BF00435221PubMedView ArticleGoogle Scholar
- Kind P, Dolan P, Gudex C, Williams A: Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 1998, 316: 736–741.PubMed CentralPubMedView ArticleGoogle Scholar
- Van Agt H, Essink-Bot ML, Krabbe P, Bonsel G: Test re-test reliability of health state valuations collected with the EuroQoL questionnaire. Soc Sci Med 1994, 39: 1537–1544. 10.1016/0277-9536(94)90005-1PubMedView ArticleGoogle Scholar
- Hurst NP, Jobanputra P, Hunter M, Lambert M, Lochead A, Brown H: Validity of EuroQoL - a generic health status instrument - in patients with rheumatoid arthritis. British Journal of Rheumatology 1994, 33: 656–662.Google Scholar
- Aspinal F, Hughes R, Higginson IJ, Chidgey J, Drescher U, Thompson M: A user's guide to the Palliative Outcome Scale. London , Palliative Care and Policy Publications; 2002.Google Scholar
- Hearn J, Higginson IJ: Development and validation of a core outcome measure for palliative care: the palliative care outcome scale. Quality in Health Care 1999, 8: 219–227.PubMed CentralPubMedView ArticleGoogle Scholar
- Herth K: Hope in the family caregiver of terminally ill people. J Adv Nurs 1993, 18: 538–548. 10.1046/j.1365-2648.1993.18040538.xPubMedView ArticleGoogle Scholar
- Bentler PM: EQS: Structural Equations Manual. Los Angeles, BMDP Statistical Software; 1989.Google Scholar
- Dunn G, Everitt B, Pickles A: Modelling Covariances and Latent Variables using EQS. Chapman and Hall ; 1993.Google Scholar
- Dolan P: Modelling valuations for EuroQoL health states. Medical Care 1997, 35: 1095–1108. 10.1097/00005650-199711000-00002PubMedView ArticleGoogle Scholar
- Johnson JA, Coons SJ, Ergo A, Szava-Kovats G: Valuation of EuroQoL (EQ-5D) health states in an adult US sample. Pharmacoeconomics 1998, 13: 421–433.PubMedView ArticleGoogle Scholar
- Franks P, Lubetkin EI, Gold MR, Tancredi DJ, Jia H: Mapping the SF-12 to the EuroQoL EQ-5D index in a national US sample. Medical Decision Making 2004, 24: 247–254. 10.1177/0272989X04265477PubMedView ArticleGoogle Scholar
- Khayat D: Quality of life: It's never too late. J Clin Oncol 2002, 20: 2915–2917.PubMedGoogle Scholar
- Higginson IJ, Costantini M: Communication in end-of-life cancer care: a comparison of team assessments in three European countries. J Clin Oncol 2002, 20: 3674–3682. 10.1200/JCO.2002.11.008PubMedView ArticleGoogle Scholar
- King M, Speck P, Thomas A: The Royal Free Interview for religious and spiritual beliefs: development and standardization. Psychol Med 1995, 25: 1125–1134.PubMedView ArticleGoogle Scholar
- McClain CS, Rosenfeld B, Breitbart W: Effect of spiritual well-being on end-of-life despair in terminally-ill cancer patients. Lancet 2003, 361: 1603–1607. 10.1016/S0140-6736(03)13310-7PubMedView ArticleGoogle Scholar
- Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny H, Norton L, al : The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. European Journal of Cancer 1994, 30A: 1326–1336. 10.1016/0959-8049(94)90182-1PubMedView ArticleGoogle Scholar
- Modi S, Panageas KS, Duck ET, Bach A, Weinstock N, Dougherty J, Cramer L, Hudis C, Norton L, Seidman A: Prospective explanatory analysis of the association between tumour response, quality of life, and expenditures among patients receiving paclitaxel monotherapy for refractory metastatic breast cancer. J Clin Oncol 2002, 20: 3665–3673. 10.1200/JCO.2002.08.057PubMedView ArticleGoogle Scholar
- Sherry KL, McAuley G: Symptom prevalence and the use of systematic symptom assessment. Palliat Med 2004, 18: 75–76.PubMedView ArticleGoogle Scholar
- Higginson IJ, Wade AM, McCarthy M: Effectiveness of two palliative support teams. J Public Health Med 1992, 14: 50–56.PubMedGoogle Scholar
- Gysels M, Higginson IJ: Improving supportive and palliative care for adults with cancer: Research Evidence. London, National Institute of Clinical Excellence; 2004. [http://www.nice.org.uk/pdf/csgsresearchevidence.pdf]Google Scholar
- Harding R, Higginson IJ: What is the best way to help caregivers in cancer and palliative care? A systematic review of interventions and their effectiveness. Palliat Med 2003, 17: 63–74. 10.1191/0269216303pm667oaPubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.